Advanced Current Issue First Edition e-Letters Future Articles Blood Collectionsi Archives sax Blood

George Mulligan 1 , * , David I. Lichter 1 , Alessandra Di Bacco 1 , Stephen J. Blakemore 1 , Allison Berger 1 , Erik Koenig 1 , Hugues Bernard 1 , William Trepicchio 1 , Bin Li 1 , Rachel Neuwirth 1 , Nibedita Chattopadhyay 1 , Joseph B. Bolen 1 , Andrew J. Dorner 1 , Helgi van de Velde 2 , Deborah Ricci 3 , Sundar Jagannath 4 , James R. Berenson 5 , Paul G. Richardson 6 , Edward A. Stadtmauer 7 , Robert Z. Orlowski 8 , Sagar Lonial 9 , Kenneth C. Anderson 6 , Pieter Sonneveld 10 , Jesús F. San Miguel 11 , Dixie-Lee Esseltine 1 , and Matthew Schu 1 1 Takeda Pharmaceuticals International Co., Cambridge, MA, United States; 2 Janssen Research & Development, Division of Janssen Pharmaceutica NV, Beerse, Belgium; 3 Janssen Research and Development, Raritan, NJ, United States; 4 Mount Sinai Hospital, New York, NY, United States; 5 Institute for Myeloma and Bone Cancer sax Research, West Hollywood, CA, United States; 6 Dana-Farber Cancer Institute, Boston, MA, United States; 7 University of Pennsylvania Abramson Cancer Center, Philadelphia, PA, United States; 8 Department of Lymphoma/Myeloma, Division of Cancer Medicine, The University of Texas M. D. Anderson Cancer Center, sax Houston, TX, United States; 9 Winship Cancer sax Institute, Emory University, Atlanta, GA, United sax States; 10 Department of Hematology, Erasmus Medical Centre, University sax Hospital Rotterdam, Rotterdam, Netherlands; sax 11 Clinica Universidad de Navarra, Centro de Investigacion Medica Aplicada (CIMA), Pamplona, Spain * Corresponding sax author; email: george.mulligan{at}takeda.com
Advanced Current Issue First Edition e-Letters Future Articles Blood Collectionsi Archives sax Blood Covers Submit to Blood Search Blood Journal App ASH sup xmlns=""> ASH Homepage sax Save Annual Meeting Membership Publications Education & Training Meeting Abstracts Email Alerts